Yu Jo Chua

Summary

Publications

  1. doi request reprint Progress and challenges in the adjuvant treatment of stage II and III colon cancers
    Yu Jo Chua
    The Canberra Hospital, Australian Capital Territory, Australia
    Expert Rev Anticancer Ther 8:595-604. 2008
  2. ncbi request reprint Recent advances in management of small-cell lung cancer
    Yu Jo Chua
    Medical Oncology Unit, The Canberra Hospital, P O Box 11, Woden, ACT 2606, Australia
    Cancer Treat Rev 30:521-43. 2004
  3. ncbi request reprint Recent data with anti-epidermal growth factor receptor antibodies and irinotecan in colon cancer
    Yu Jo Chua
    Department of Medicine, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, UK
    Clin Colorectal Cancer 5:S81-8. 2005
  4. ncbi request reprint Pharmacotherapy for oesophagogastric cancer
    Christopher Jackson
    Gastrointestinal and Lymphoma Units, Royal Marsden Hospital, London and Surrey, United Kingdom
    Drugs 67:2539-56. 2007
  5. ncbi request reprint Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    David Cunningham
    Department of Medicine, Royal Marsden Hospital, Sutton, Surrey, United Kingdom
    N Engl J Med 355:11-20. 2006
  6. ncbi request reprint East meets west in the treatment of gastric cancer
    David Cunningham
    N Engl J Med 357:1863-5. 2007
  7. ncbi request reprint The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice
    Yu Jo Chua
    Ann Surg Oncol 14:2687-90. 2007
  8. doi request reprint Epidermal growth factor receptor inhibitor-related skin toxicity: mechanisms, treatment, and its potential role as a predictive marker
    Diletta Bianchini
    Department of Medicine, Royal Marsden Hospital, Down s Road, Sutton, Surrey, SM2 5PT UK
    Clin Colorectal Cancer 7:33-43. 2008
  9. ncbi request reprint Current treatment strategies in elderly patients with metastatic colorectal cancer
    Hendrik Tobias Arkenau
    Department of Medical Oncology, Royal Marsden Hospital London and Sutton, Surrey, United Kingdom
    Clin Colorectal Cancer 6:508-15. 2007
  10. ncbi request reprint Adjuvant treatment for resectable pancreatic cancer
    Yu Jo Chua
    Department of Medicine, Royal Marsden Hospital, Downs Rd, Sutton, Surrey SM2 5PT, United Kingdom
    J Clin Oncol 23:4532-7. 2005

Collaborators

Detail Information

Publications13

  1. doi request reprint Progress and challenges in the adjuvant treatment of stage II and III colon cancers
    Yu Jo Chua
    The Canberra Hospital, Australian Capital Territory, Australia
    Expert Rev Anticancer Ther 8:595-604. 2008
    ....
  2. ncbi request reprint Recent advances in management of small-cell lung cancer
    Yu Jo Chua
    Medical Oncology Unit, The Canberra Hospital, P O Box 11, Woden, ACT 2606, Australia
    Cancer Treat Rev 30:521-43. 2004
    ..The future of SCLC treatment may however lie with molecularly targeted therapies, such as antiangiogenesis agents and signal transduction inhibitors, which are being studied at present...
  3. ncbi request reprint Recent data with anti-epidermal growth factor receptor antibodies and irinotecan in colon cancer
    Yu Jo Chua
    Department of Medicine, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, UK
    Clin Colorectal Cancer 5:S81-8. 2005
    ..This article reviews the recent evidence supporting the combination of these anti-EGFR agents with the cytotoxic chemotherapeutic agent irinotecan...
  4. ncbi request reprint Pharmacotherapy for oesophagogastric cancer
    Christopher Jackson
    Gastrointestinal and Lymphoma Units, Royal Marsden Hospital, London and Surrey, United Kingdom
    Drugs 67:2539-56. 2007
    ..We examine areas of current research and highlight future therapeutic directions...
  5. ncbi request reprint Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    David Cunningham
    Department of Medicine, Royal Marsden Hospital, Sutton, Surrey, United Kingdom
    N Engl J Med 355:11-20. 2006
    ..We assessed whether the addition of a perioperative regimen of ECF to surgery improves outcomes among patients with potentially curable gastric cancer...
  6. ncbi request reprint East meets west in the treatment of gastric cancer
    David Cunningham
    N Engl J Med 357:1863-5. 2007
  7. ncbi request reprint The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice
    Yu Jo Chua
    Ann Surg Oncol 14:2687-90. 2007
  8. doi request reprint Epidermal growth factor receptor inhibitor-related skin toxicity: mechanisms, treatment, and its potential role as a predictive marker
    Diletta Bianchini
    Department of Medicine, Royal Marsden Hospital, Down s Road, Sutton, Surrey, SM2 5PT UK
    Clin Colorectal Cancer 7:33-43. 2008
    ..This review aims to summarize and update the current knowledge of the clinical presentation, predictive and prognostic value, and the management of EGFRI-related skin toxicity...
  9. ncbi request reprint Current treatment strategies in elderly patients with metastatic colorectal cancer
    Hendrik Tobias Arkenau
    Department of Medical Oncology, Royal Marsden Hospital London and Sutton, Surrey, United Kingdom
    Clin Colorectal Cancer 6:508-15. 2007
    ..This article reviews the development of treatment for elderly patients with metastatic CRC, from single-agent fluoropyrimidines to combination therapies...
  10. ncbi request reprint Adjuvant treatment for resectable pancreatic cancer
    Yu Jo Chua
    Department of Medicine, Royal Marsden Hospital, Downs Rd, Sutton, Surrey SM2 5PT, United Kingdom
    J Clin Oncol 23:4532-7. 2005
    ..The optimal chemotherapy regimen for use as adjuvant treatment is the subject of ongoing trials. Other strategies which should be explored include neoadjuvant treatment and the incorporation of novel targeted agents into management...
  11. ncbi request reprint Neoadjuvant treatment of unresectable liver metastases from colorectal cancer
    Yu Jo Chua
    Department of Medicine, Royal Marsden Hospital, Surrey and London, United Kingdom
    Clin Colorectal Cancer 5:405-12. 2006
    ....
  12. ncbi request reprint Chemotherapy for advanced pancreatic cancer
    Yu Jo Chua
    Department of Medicine, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, UK
    Best Pract Res Clin Gastroenterol 20:327-48. 2006
    ..This article will review and discuss the clinical trials of chemotherapy for this disease, including the more recent trials, which have included the novel targeted agents...
  13. ncbi request reprint Panitumumab
    Yu Jo Chua
    Department of Medicine, Royal Marsden Hospital, London and Surrey, UK
    Drugs Today (Barc) 42:711-9. 2006
    ..Clinical trial results in colorectal cancer, in which the development of this agent is most advanced, will also be discussed, as will the rash associated with treatment...